In Response:
I fully agree with the comments in Dr. Shimada's letter regarding the respect researchers should have for the originator of cell lines. Similarly, researchers should respect and appreciate all originators who produce and provide materials and agents in our biomedical research. I strongly believe that this is an important issue in our scientific activity.
We appreciate the questions raised by Dr. Shimada regarding KYSE-9706, Colo-680, and KYSE-2 and apologize for typographic errors in the names of these cell lines. Regarding KYSE-9706, most of time in our article, we used the term 9706 instead of KYSE-9706. The exact name of this line is EC9706, which was established by Dr. Mingrong Wang (State Key Laboratory of Molecular Oncology, Beijing, China). This work was published in 2002 (1). In the legend of Fig. 3B , however, 9706 was mislabeled as KYSE-9706. Regarding Colo-680, the correct name of this cell line is Colo-680N. It is an esophageal squamous cell carcinoma and was established by Dr. G.E. Moore (Colorado Oncology Foundation, Denver, CO). Finally, the correct name of KYSE-2 is YSE-2, derived from a human squamous cell carcinoma (2). 
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